{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T21:37:33Z","timestamp":1783287453928,"version":"3.54.6"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amjms.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:52:15Z","timestamp":1748951535000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cirrhosis and hyponatremia: A review of pathogenesis, clinical relevance, and management"],"prefix":"10.1016","volume":"370","author":[{"given":"Jackeline","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Ortiz","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cld.2022.01.001","article-title":"Hyponatremia in Cirrhosis","volume":"26","author":"Rondon-Berrios","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0003","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ajt.16142","article-title":"Validation of the model for end-stage liver disease sodium (MELD-Na) score in the eurotransplant region","volume":"21","author":"Goudsmit","year":"2021","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: the model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13098","article-title":"MELD3.0 is superior to MELDNa and MELD for prediction of mortality in patients with cirrhosis: an external validation in a multi-ethnic population","volume":"8","author":"Lin","year":"2024","journal-title":"JGH Open"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0007","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/gastroent14040033","article-title":"Clinical significance and management of hyponatremia in liver cirrhosis","volume":"14","author":"Jani\u010dko","year":"2023","journal-title":"Gastroenterol Insights"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0008","first-page":"116","article-title":"Frequency of hyponatraemia and its influence on liver cirrhosis-related complications","volume":"60","author":"Shaikh","year":"2010","journal-title":"J Pak Med Assoc"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0009","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2025.06.004_bib0010","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2020\/46798.14225","article-title":"Clinical significance of serum sodium levels in liver cirrhosis: a cross-sectional observational study","author":"Nareddy","year":"2020","journal-title":"J Clin Diagn Res."},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0011","first-page":"1349","article-title":"Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis","volume":"7","author":"Barakat","year":"2015","journal-title":"Electron Physician"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.004_bib0012","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update","volume":"115","author":"Alukal","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/gastro\/got037","article-title":"Hyponatraemia and cirrhosis","volume":"2","author":"Gianotti","year":"2014","journal-title":"Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0014","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.1984.136","article-title":"Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis","volume":"26","author":"P\u00e9rez-Ayuso","year":"1984","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0016","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1756283X12454590","article-title":"The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?","volume":"6","author":"Bien","year":"2013","journal-title":"Ther Adv Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.004_bib0019","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gutjnl-2012-303954","article-title":"Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome","volume":"62","author":"Knights","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current understanding of dysbiosis in disease in human and animal models","volume":"22","author":"DeGruttola","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"21","key":"10.1016\/j.amjms.2025.06.004_bib0021","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3748\/wjg.v18.i21.2609","article-title":"Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis","volume":"18","author":"Ilan","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.004_bib0022","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/liv.12271","article-title":"Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature","volume":"33","author":"Pijls","year":"2013","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0023","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2013.11.051","article-title":"Mechanisms of obesity-induced gastrointestinal neoplasia","volume":"146","author":"Alem\u00e1n","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0024","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The brain-gut-microbiome axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.004_bib0026","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1053\/j.gastro.2022.01.058","article-title":"Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective","volume":"162","author":"Bauer","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain axis in patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.004_bib0028","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"R\u00f6ssle","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0029","first-page":"986","article-title":"Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters","volume":"21","author":"Quiroga","year":"1995","journal-title":"Hepatol Baltim Md"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.004_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0031","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/gastro\/gox010","article-title":"Ascites, refractory ascites and hyponatremia in cirrhosis","volume":"5","author":"Fortune","year":"2017","journal-title":"Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0032","first-page":"245","article-title":"[Comparison of biochemical parameters of the blood and ascitic fluid in hepatic cirrhosis]","volume":"69","author":"Mart\u00ednez Ballar\u00edn","year":"1986","journal-title":"Rev Esp Enferm Apar Dig"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.004_bib0033","first-page":"203","article-title":"Study of ascitic fluid in relation to systemic and portal venous blood in hepatic cirrhosis","volume":"89","author":"Mukherjee","year":"1991","journal-title":"J Indian Med Assoc"},{"issue":"8","key":"10.1016\/j.amjms.2025.06.004_bib0034","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejim.2007.07.011","article-title":"Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood","volume":"19","author":"Nguyen-Khac","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.17941\/agd.977865","article-title":"The prognostic utility of ascites sodium level in cirrhotic patients","volume":"20","author":"Kaplan","year":"2021","journal-title":"Akad Gastroenteroloji Derg"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0036","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2036.2004.02081.x","article-title":"Review article: hepatic hydrothorax","volume":"20","author":"Cardenas","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0037","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(99)00217-X","article-title":"Hepatic hydrothorax: pathogenesis, diagnosis, and management","volume":"107","author":"Lazaridis","year":"1999","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0038","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00003072-199503000-00022","article-title":"Hepatic hydrothorax. Scintigraphic confirmation","volume":"20","author":"Park","year":"1995","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.amjms.2025.06.004_bib0039","doi-asserted-by":"crossref","unstructured":"Kamath S., Sunder A. Hepatic hydrothorax in the absence of ascites: a diagnostic challenge. Cureus. 13(7):e16650. doi:10.7759\/cureus.16650.","DOI":"10.7759\/cureus.16650"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.004_bib0040","first-page":"566","article-title":"Frequency of hepatic hydrothorax and its association with child pugh class in liver cirrhosis patients","volume":"26","author":"Abbasi","year":"2016","journal-title":"J Coll Physicians Surg\u2013Pak JCPSP"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0041","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtcvs.2004.08.051","article-title":"The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding","volume":"130","author":"Huang","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjms.2025.06.004_bib0042","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-12-26","article-title":"Quantitative modeling of the physiology of ascites in portal hypertension","volume":"12","author":"Levitt","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0043","first-page":"157","article-title":"Reabsorption of ascites and the factors that affect this process in cirrhosis","volume":"152","author":"Akay","year":"2008","journal-title":"Transl Res J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0044","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-8278(00)00009-X","article-title":"Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis","volume":"34","author":"Henriksen","year":"2001","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0045","first-page":"166","article-title":"Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration","volume":"111","author":"Rector","year":"1988","journal-title":"J Lab Clin Med"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.004_bib0046","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4254\/wjh.v15.i10.1140","article-title":"Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: an often unconsidered mechanism","volume":"15","author":"Arya","year":"2023","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0047","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s12072-023-10592-z","article-title":"Lymphatic drainage dysfunction is related to clinically significant portal hypertension","volume":"17","author":"Ma","year":"2023","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0048","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CRD.0000000000000469","article-title":"Pleural effusions in patients with congestive heart failure: frequency, pathogenesis, diagnosis, and implications","volume":"32","author":"Elgwairi","year":"2024","journal-title":"Cardiol Rev"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0049","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v13.i3.300","article-title":"Lymphatic dysfunction in advanced cirrhosis: contextual perspective and clinical implications","volume":"13","author":"Kumar","year":"2021","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1152\/ajplegacy.1973.224.4.857","article-title":"Pleural fluid-plasma bicarbonate gradients in oxygen-toxic and normal rats","volume":"224","author":"Rolf","year":"1973","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0034-5687(91)90044-J","article-title":"Electrolyte transport across the pleura of rabbits","volume":"86","author":"Zocchi","year":"1991","journal-title":"Respir Physiol"},{"key":"10.1016\/j.amjms.2025.06.004_bib0052","doi-asserted-by":"crossref","unstructured":"Kataoka H. Effusion-serum chloride gradient in heart failure-associated pleural Effusion\u2015 pathophysiologic implications \u2015. Circ Rep. 2(7):357\u2013363. doi:10.1253\/circrep.CR-20-0018.","DOI":"10.1253\/circrep.CR-20-0018"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0053","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gut.49.6.847","article-title":"Sodium homeostasis with chronic sodium loading in preascitic cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"issue":"43","key":"10.1016\/j.amjms.2025.06.004_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035596","article-title":"Association of serum sodium and 24-hour urinary sodium level with the severity and complications of ascites in cirrhotic patients","volume":"102","author":"Islam","year":"2023","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.004_bib0055","first-page":"1149","article-title":"Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function","volume":"26","author":"Wensing","year":"1997","journal-title":"Hepatol Baltim Md"},{"issue":"9","key":"10.1016\/j.amjms.2025.06.004_bib0056","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1515\/cclm-2018-0963","article-title":"Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias","volume":"57","author":"Tel-Karthaus","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0057","doi-asserted-by":"crossref","first-page":"835","DOI":"10.14309\/ajg.0000000000001011","article-title":"Measuring serum sodium in cirrhosis: regarding \u201chyponatremia in cirrhosis: an update","volume":"116","author":"Morton","year":"2021","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0058","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4240\/wjgs.v16.i3.751","article-title":"Clinical study on the relationship between liver cirrhosis, ascites, and hyponatremia","volume":"16","author":"Li","year":"2024","journal-title":"World J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0059","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal Syndrome: 2021 practice guidance by the American Association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatol Baltim Md"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.004_bib0060","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","article-title":"Hyponatremia in cirrhosis: pathophysiology and management","volume":"21","author":"John","year":"2015","journal-title":"World J Gastroenterol WJG"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0061","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial","volume":"37","author":"Wong","year":"2003","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0062","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0063","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2229-516X.106347","article-title":"Vaptans: a new option in the management of hyponatremia","volume":"2","author":"Aditya","year":"2012","journal-title":"Int J Appl Basic Med Res"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0064","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.07.033","article-title":"Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis","volume":"62","author":"Ahluwalia","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjms.2025.06.004_bib0065","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2019.01365","article-title":"Impact of vaptans on clinical outcomes in cirrhosis patients: a meta-analysis of randomized controlled trials","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.004_bib0066","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/apt.12025","article-title":"Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia","volume":"36","author":"Dahl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124105","article-title":"Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis","volume":"10","author":"Corona","year":"2015","journal-title":"PloS One"},{"issue":"17","key":"10.1016\/j.amjms.2025.06.004_bib0068","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2169\/internalmedicine.0629-17","article-title":"Association between the serum sodium levels and the response to Tolvaptan in liver cirrhosis patients with ascites and hyponatremia","volume":"57","author":"Hayashi","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.004_bib0069","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2016.09.011","article-title":"Limited efficacy of Tolvaptan in patients with cirrhosis and severe hyponatremia: real-life experience","volume":"130","author":"Pose","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.amjms.2025.06.004_bib0070","doi-asserted-by":"crossref","unstructured":"Khan M.Y., Rawala M.S., Siddiqui M., et al. Tolvaptan-induced liver injury: who is at risk? A case report and literature review. Cureus. 11(6):e4842. doi:10.7759\/cureus.4842.","DOI":"10.7759\/cureus.4842"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.004_bib0071","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40264-015-0327-3","article-title":"Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of Clinical trials database","volume":"38","author":"Watkins","year":"2015","journal-title":"Drug Saf"},{"issue":"19","key":"10.1016\/j.amjms.2025.06.004_bib0072","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/jcm11195928","article-title":"Use of Human albumin Administration for the prevention and treatment of hyponatremia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"11","author":"Bai","year":"2022","journal-title":"J Clin Med"},{"issue":"10138","key":"10.1016\/j.amjms.2025.06.004_bib0073","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0074","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14309\/ajg.0000000000001995","article-title":"Correction and prevention of hyponatremia in patients with cirrhosis and ascites: post hoc analysis of the ANSWER Study Database","volume":"118","author":"Zaccherini","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.004_bib0075","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0076","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites","volume":"39","author":"Di Pascoli","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0077","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/0897190021997002","article-title":"Albumin utilization in spontaneous bacterial peritonitis","volume":"35","author":"Ebied","year":"2022","journal-title":"J Pharm Pract"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.004_bib0078","first-page":"9","article-title":"AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update","volume":"19","author":"Caraceni","year":"2021","journal-title":"Blood Transfus"},{"issue":"12","key":"10.1016\/j.amjms.2025.06.004_bib0079","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjmed.2013.07.021","article-title":"Prevalence of hyponatremia and association with mortality: results from NHANES","volume":"126","author":"Mohan","year":"2013","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.amjms.2025.06.004_bib0080","article-title":"Hyponatremia and outcome: is severity more important than etiology?","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.004_bib0081","first-page":"39","article-title":"Biochemical analysis of pleural fluid and ascites","volume":"39","author":"Chubb","year":"2018","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.004_bib0082","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis \u2013 Current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J Hepatol"},{"issue":"11S","key":"10.1016\/j.amjms.2025.06.004_bib0083","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.20223311S158c","article-title":"Impact of terlipressin on serum sodium levels in patients with hepatorenal syndrome (HRS): the North American experience: TH-PO035","volume":"33","author":"Merwat","year":"2022","journal-title":"J Am Soc Nephrol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:34:33Z","timestamp":1755614073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925010663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002962925010663"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.004","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cirrhosis and hyponatremia: A review of pathogenesis, clinical relevance, and management","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}